KOSELUGO 25 mg/1

Koselugo 25 mg capsules are a medication used to manage specific conditions. This oral treatment is designed to support therapeutic needs, offering a targeted approach.

Koselugo 25 mg capsules are primarily used for the treatment of neurofibromatosis type 1 (NF1) in pediatric patients. This medication is indicated for symptomatic, inoperable plexiform neurofibromas. It is important to consult with a healthcare provider to determine if Koselugo is suitable for your specific condition.

Common effects of Koselugo 25 mg capsules may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some patients may also experience fatigue, skin reactions, or changes in blood pressure. Always monitor your body's response and report any severe or persistent effects to your healthcare provider.

Koselugo 25 mg capsules should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Keep the capsules out of reach of children and pets. Always follow the instructions provided by your healthcare provider regarding the administration and storage of this medication.

Koselugo 25 mg capsules may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions. Avoid consuming alcohol while taking this medication unless advised otherwise by your healthcare provider.